Cost-effectiveness and pricing of caffeine

Area of Science:

• Neonatal pharmacology
• Health economics
• Pharmaceutical pricing

Background:

• Caffeine citrate is a key treatment for apnea of prematurity.
• Previous economic evaluations showed caffeine reduced costs and improved outcomes.
• Current pharmaceutical prices, including caffeine, have increased significantly, impacting medical costs.

Purpose of the Study:

• To review the pricing determinants for neonatology formulary drugs.
• To analyze factors contributing to rising pharmaceutical costs in neonatology.
• To provide strategies for ensuring drug efficacy and cost-effectiveness.

Main Methods:

• Review of economic evaluations and pharmaceutical pricing models.
• Analysis of market dynamics, regulatory policies, and buyer behavior.
• Examination of case studies, including caffeine and surfactant pricing.

Main Results:

• Pharmaceutical pricing in neonatology is influenced by small market size, regulatory barriers, high willingness-to-pay, and information asymmetry.
• These factors contribute to increased drug costs and healthcare inflation.
• Despite market challenges, neonatologists can influence drug value.

Conclusions:

• Neonatal drug pricing is complex, driven by market and policy factors.
• Rigorous clinical trials and economic evaluations are crucial for informed prescribing.
• Neonatologists play a vital role in ensuring efficacious and cost-effective drug use in neonates.